Lung Diseases clinical trials at UCSF

1 research study open to eligible people

Lung diseases harm airways or lung tissue and make breathing difficult. UCSF is involved in a large, multi-center study that will enroll roughly 4,000 adults aged 25 to 35 who do not have severe lung disease. UCSF is tracking breathing measures and health data over several years.

Showing trials for

  • American Lung Association (ALA) Lung Health Cohort

    open to eligible people ages 25-35

    The ALA-LHC is a longitudinal, multi-center cohort study that will enroll approximately 4,000 young adults between the ages of 25-35 who do not have severe lung disease. The overarching objective of the ALA-LHC is to establish a national cohort of young adults for the purpose of defining lung health and developing targets to intercept chronic lung disease at its earliest stages.

    San Francisco, California and other locations

Our lead scientists for Lung Diseases research studies include .

Last updated: